F
| Factor V HR2 |
| Factor V Leiden |
| Factor VII |
| Factor XIII |
| FGFR1(8p11) for Myeloid and Lymphoid Neoplasms with Eosinophilia (HES/CEL) |
| FGFR3/IGH t(4;14)(4p16,14q32) for Multiple Myeloma prognosis |
| β Fibrinogen |
| FIP1L1/CHIC2/PDGFR A(4q12) for Myeloid and Lymphoid Neoplasms with Eosinophilia (HES/CEL) |
| FIP1L1-PDGFRA Exon 9 ,10,11,12,13 for Clonal Eosinophilia |
| FLT3-D835 Mutation for AML (prognostic marker) |
| FLT3-ITD Mutation for AML (prognostic marker) |
| 5- Fluorouracil ( 5-FU) toxicity DPYD IVS 14+1 G>A polymorphism |
| Follicular Lymphoma panel at diagnosis ( 12-15 CD markers) |
| Foreign bodies/ culture |